MD Anderson Cancer Center, Houston Texas
University of California Irvine Medical Center
Debbie Stephens – University of Utah
Chitra Hosing – MD Anderson Cancer Center
Susan O’Brien – University of California Irvine Medical Center
Nitin Jain – MD Anderson Cancer Center
David Maloney – Fred Hutchinson Cancer Center
Nitin Jain – MD Anderson Cancer Center
Kerry Rogers – The Ohio State University
Jennifer Woyach – The Ohio State University
Nathalie Johnson – McGill
John Byrd – University of Cincinnati
Alessandra Ferrajoli – MD Anderson Cancer Center, Houston, Texas
Danielle Brander – Duke University School of Medicine
Clare Sun – National Heart, Lung and Blood Institute
Lili Wang – City of Hope
Sameer Parikh – Mayo Clinic
Dai Chihara – MD Anderson Cancer Centre
Sandeep Dave – Duke University School of Medicine
Sandeep Dave – Duke University School of Medicine
Christopher Flowers – MD Anderson Cancer Center
Sattva Neelapu – MD Anderson Cancer Center
Caron Jacobson – Dana Farber Cancer Institute
Paolo Strati – MD Anderson Center
John Leonard – Weill Cornell Medicine
Elizabeth Brem – UCI Health Cancer Center
Julie Vose – University of Nebraska
Swami Iyer – MD Anderson Cancer Center
Ranjana Advani – Stanford University
Paolo Strati – MD Anderson Center
Swetha Kambhampati – City of Hope
It is our pleasure to invite you to participate in this one-of-a-kind event.
If you need additional information please contact us at:
MD Education Ltd
4/4a Bloomsbury Square,
London, WC1A 2RP
MD Education USA LLC
4600 140th Avenue North, Suite 180,
Clearwater, Florida 33762
Paolo Strati MD is currently an Assistant Professor, Term Tenure Track, in the Department of Lymphoma and Myeloma with a joint appointment in the Department of Translational Molecular Pathology, at the University of Texas MD Anderson Cancer Center, in Houston, TX, and previously served as Assistant Professor at the Mayo Clinic, in Rochester (MN).
Dr. Strati earned his medical degree cum laude from the San Raffaele University of Milan (Italy) in 2008, and completed an Internal Medicine Residency at the same institution and, subsequently, at the Mayo Clinic, in Rochester (MN). He also completed a Hematology-Oncology Fellowship at MD Anderson Cancer Center, a Leukemia and Lymphoma fellowship at the same institution, and a Malignant Hematology fellowship at the Barts Cancer Institute, in London (UK).
Dr. Strati is a recognized expert in the field of immunotherapy and cellular therapy for the treatment of B-cell lymphoma, and he is the principal investigator of multiple clinical trials and translational projects related to this topic. He is author of several peer-reviewed manuscripts published on high impact journal, including Blood and Lancet Haematology, and he is regularly invited to present his work at international scientific meetings, including the American Society of Hematology and the American Society of Clinical Oncology conference. In light of his research accomplishments, he has received multiple grants and awards, including a NIH R21 grant, the Lymphoma Research Foundation Career Development Award and the Leukemia Lymphoma Society Career Development Award.
Dr. Strati is committed to gain further insight into the biology of the lymphoma immune microenvironment, and to manipulate its components successfully, in order to develop novel effective therapies and to decrease the toxicity of treatment strategies already available for patients with B-cell lymphoma.
Dr. Elizabeth Brém is currently a Clinical Associate Professor at the University of California, Irvine, with a clinical focus in lymphomas, CLL, and multiple myeloma. She earned her medical degree from the University of Buffalo summa cum laude with thesis honors and completed her residency in Internal Medicine and fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center/Harvard Medical School in Boston, MA. Dr. Brém serves as the chair of the University of California Hematologic Malignancies Consortium Lymphoma/CLL committee and is an active member of ASH, having served on a number of committees and as a former Associate Editor of ASH Clinical News. Dr. Brém is also active in the NCTN and is currently the study chair of SWOG S1918, a study for patients age 75 and older with a new diagnosis of DLBCL. She has participated in a number of high-profile mentoring programs and in 2021 was awarded the Coltman Fellowship from the Hope Foundation to support her efforts on S1918.
